688767 博拓生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.9387.0274.28433.144--
总资产报酬率 ROA (%)0.8776.5433.99929.852--
投入资产回报率 ROIC (%)0.9336.9424.18932.497--

边际利润分析
销售毛利率 (%)46.28452.84250.33153.46161.831
营业利润率 (%)7.36734.57426.42448.09453.162
息税前利润/营业总收入 (%)1.38624.1056.81239.66353.371
净利润/营业总收入 (%)6.61829.81323.81840.68945.969

收益指标分析
经营活动净收益/利润总额(%)76.428101.594123.529105.381100.559
价值变动净收益/利润总额(%)14.1143.6162.9171.6470.110
营业外收支净额/利润总额(%)0.1550.776-0.817-1.3800.217

偿债能力分析
流动比率 (X)13.65810.51413.96613.066--
速动比率 (X)13.08210.10313.30112.275--
资产负债率 (%)5.4457.2936.1576.879--
带息债务/全部投入资本 (%)0.189-0.1381.6831.666--
股东权益/带息债务 (%)52,647.015-72,239.2305,818.7475,859.963--
股东权益/负债合计 (%)1,735.4201,269.5761,520.7341,353.085--
利息保障倍数 (X)-0.231-2.245-0.351-5.100569.766

营运能力分析
应收账款周转天数 (天)79.86751.27441.00417.5850.000
存货周转天数 (天)118.468117.856192.23956.3330.000